[go: up one dir, main page]

PE20131337A1 - Composicion anestesica nanoparticulada para la administracion topica - Google Patents

Composicion anestesica nanoparticulada para la administracion topica

Info

Publication number
PE20131337A1
PE20131337A1 PE2013000512A PE2013000512A PE20131337A1 PE 20131337 A1 PE20131337 A1 PE 20131337A1 PE 2013000512 A PE2013000512 A PE 2013000512A PE 2013000512 A PE2013000512 A PE 2013000512A PE 20131337 A1 PE20131337 A1 PE 20131337A1
Authority
PE
Peru
Prior art keywords
nanoparticulated
topical administration
anesthetic composition
concents
composition
Prior art date
Application number
PE2013000512A
Other languages
English (en)
Inventor
Guterres Silvia Stanisçuaski
Junior Dante Alario
Pohlmann Adriana Raffin
Original Assignee
Biolab Sanus Farmacêutica Ltda
Univ Fed Do Rio Grande Do Sul
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39765309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20131337(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biolab Sanus Farmacêutica Ltda, Univ Fed Do Rio Grande Do Sul filed Critical Biolab Sanus Farmacêutica Ltda
Publication of PE20131337A1 publication Critical patent/PE20131337A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) UNA SUSPENSION DE NANOPARTICULAS POLIMERICAS CONSTITUIDA DE UN POLIMERO SELECCIONADO DEL GRUPO CONSTITUIDO POR POLI ( ?-CAPROLACTONA), POLIMETACRILATO DE METILO ENTRE OTROS, MEZCLAS DE ACTIVOS DE LIDOCAINA EN LA CONCENTRACION DE 0,5-10% Y PRILOCAINA EN LA CONCENTRACION DE 0,5-10%, TENSOACTIVO Y AGUA, DICHAS NANOPARTICULAS PRESENTA UN TAMANO DE DIMENSIONES INFERIORES A 0.2 µm.; B)UN CARBOXIPOLIMETILENO COMO AGENTE DE VISCOSIDAD. DICHA COMPOSICION TIENE UNA VISCOSIDAD EN EL RANGO DE 100000 A 800000 CP.
PE2013000512A 2007-03-16 2008-03-13 Composicion anestesica nanoparticulada para la administracion topica PE20131337A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0700832A BRPI0700832B8 (pt) 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína

Publications (1)

Publication Number Publication Date
PE20131337A1 true PE20131337A1 (es) 2013-11-18

Family

ID=39765309

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2008000474A PE20081883A1 (es) 2007-03-16 2008-03-13 Composicion anestesica nanoparticulada para la administracion topica
PE2013000512A PE20131337A1 (es) 2007-03-16 2008-03-13 Composicion anestesica nanoparticulada para la administracion topica

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PE2008000474A PE20081883A1 (es) 2007-03-16 2008-03-13 Composicion anestesica nanoparticulada para la administracion topica

Country Status (15)

Country Link
US (1) US8568788B2 (es)
EP (1) EP2134334B1 (es)
JP (1) JP5496684B2 (es)
AR (1) AR065723A1 (es)
BR (1) BRPI0700832B8 (es)
CL (1) CL2008000728A1 (es)
CO (1) CO6220944A2 (es)
EC (1) ECSP099691A (es)
ES (1) ES2804466T3 (es)
HU (1) HUE051155T2 (es)
MX (1) MX2009009853A (es)
PE (2) PE20081883A1 (es)
PL (1) PL2134334T3 (es)
PT (1) PT2134334T (es)
WO (1) WO2008113144A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2344329T3 (pl) 2008-10-02 2013-05-31 Mylan Inc Sposób wytwarzania wielowarstwowego laminatu przylepnego
BR102012022036B1 (pt) * 2012-08-31 2019-10-01 Biolab Sanus Farmacêutica Ltda. Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso
BR102014028009B1 (pt) 2014-11-10 2023-04-18 Universidade Federal De Pelotas Composições filmogênicas para bioadesivos anestésicos tópicos (bats) para liberação controlada de princípios ativos e bioadesivos anestésicos tópicos
US11452700B2 (en) 2017-08-04 2022-09-27 Eric Haas Method of delivering an anesthetic agent and glucocorticoid micro and nano bioerodible particles
CN113244167B (zh) * 2021-05-20 2022-11-29 河北科技大学 一种盐酸利多卡因凝胶及其制备方法
RU208882U1 (ru) * 2021-08-25 2022-01-19 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курская государственная сельскохозяйственная академия имени И.И. Иванова" Раневая атравматическая повязка для животных
CN119950421B (zh) * 2025-04-11 2025-07-08 北华大学 一种含有三甲卡因的麻醉制剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7713618L (sv) * 1977-12-01 1979-06-02 Astra Laekemedel Ab Lokalanestetisk blandning
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
DE4120760A1 (de) * 1991-06-24 1993-03-04 3 M Medica Gmbh Traegersysteme fuer arzneimittel
JPH09255565A (ja) * 1996-03-26 1997-09-30 Daikyo Yakuhin Kogyo Kk 皮膚局所麻酔用ヒドロゲルパッチ
WO1999001114A1 (en) 1997-07-02 1999-01-14 Euro-Celtique, S.A. Prolonged anesthesia in joints and body spaces
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
KR100463167B1 (ko) * 2001-04-13 2004-12-23 주식회사 태평양 고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
US20070154527A1 (en) * 2001-10-12 2007-07-05 Monosoirx, Llc Topical film compositions for delivery of actives
US20080124400A1 (en) 2004-06-24 2008-05-29 Angiotech International Ag Microparticles With High Loadings Of A Bioactive Agent
US8940311B2 (en) * 2004-10-21 2015-01-27 Tae-Hong Lim In situ controlled release drug delivery system
WO2006091719A2 (en) * 2005-02-23 2006-08-31 Sontra Medical Corporation Compositions and methods enhancing transdermal delivery of drugs and biologics

Also Published As

Publication number Publication date
BRPI0700832B8 (pt) 2021-05-25
JP2010521498A (ja) 2010-06-24
MX2009009853A (es) 2010-02-18
ECSP099691A (es) 2010-02-26
EP2134334A1 (en) 2009-12-23
US20100086614A1 (en) 2010-04-08
ES2804466T3 (es) 2021-02-08
US8568788B2 (en) 2013-10-29
BRPI0700832A (pt) 2008-11-04
WO2008113144A1 (en) 2008-09-25
CL2008000728A1 (es) 2008-09-26
CO6220944A2 (es) 2010-11-19
JP5496684B2 (ja) 2014-05-21
EP2134334A4 (en) 2013-04-24
HUE051155T2 (hu) 2021-03-01
PE20081883A1 (es) 2008-12-27
EP2134334B1 (en) 2020-05-13
PL2134334T3 (pl) 2021-03-08
AR065723A1 (es) 2009-06-24
PT2134334T (pt) 2020-08-20
BRPI0700832B1 (pt) 2017-12-26

Similar Documents

Publication Publication Date Title
PE20131337A1 (es) Composicion anestesica nanoparticulada para la administracion topica
MX336930B (es) Formulaciones de ganaxolona y metodos para la manufactura y el uso de las mismas.
ES2649340T3 (es) Administración de fármacos activados por hipoxia y agentes antiangiogénicos para el tratamiento del cáncer
ES2619309T3 (es) Ácido hialurónico sulfatado para el tratamiento de la osteoartritis degenerativa
ES2570856T3 (es) Composiciones oftálmicas que contienen una combinación sinérgica de dos polímeros
BR112015021709B8 (pt) Poli(beta-amino ésteres) modificados para administração de fármacos e nanopartícula compreendendo os mesmos, uma composição compreendendo os mesmos, método de encapsulamento de um agente em uma matriz de polímeros para formar nanopartículas, e uso dos poli(beta-amino ésteres)
AR076559A1 (es) Policarbonatos hiperramificados para la solubilizacion de principios activos de dificil disolucion
PE20110573A1 (es) Sistema de administracion de drogas que contiene progestina
UY29086A1 (es) Nuevas composiciones farmacéuticas para el tratamiento de trastornos hiperproliferativos.
CO7151506A2 (es) Formulación de fármaco de liberación retardada
AR061990A1 (es) Mejoras relacionadas a composiciones antiparasitarias
CL2009002073A1 (es) Composicion farmaceutica solida para la liberacion controlada de un agente activo activo en el tracto gastrointestinal que comprende al menos un agente acido con solubilidad de menos de 0,3 mg/ml en solucion acuosa a un ph alrededor del pka del agente acido, un polimero hidrofilo, un alcanizador; uso en trastornos cardiovasculares.
AR086115A1 (es) Formulaciones parenterales mejoradas de agentes farmaceuticos lipofilos y los metodos para la preparacion y el uso de las mismas
CR10150A (es) Formulaciones de aceite
PE20090670A1 (es) Material compuesto polimerico con funcionalidad biocida
ECSP088239A (es) Composición de liberación de fármaco sostenida
PE20100057A1 (es) Sistema de suministro intrauterino para la liberacion controlada de progestageno
AR084582A1 (es) Composiciones fluidas, metodo
AR061785A1 (es) Nanoparticulas de quitosano e hialuronano para la administracion de moleculas activas
ECSP088951A (es) /composición farmacéutica estable que contiene docetaxel y método para su fabricación
AR071334A1 (es) Gel de quitosano para aplicaciones dermatologicas, proceso de obtencion y uso del mismo
AR076422A1 (es) Eficiencia mejorada de composiciones de pantalla solar
PA8815901A1 (es) Sistema de administracion de drogas con efecto estabilizante
CL2009000625A1 (es) Composicion farmaceutica que comprende a)un primer poliol seleccionado de manitol, sorbitol o una combinacion de ambos, b)segundo poliol seleccionado de propilenglicol, glicerina o una combinacion de ambas, c)complejo de borato en un 0,5% p/v de la composicion total, d)preservante, e)agua; util para el tratamiento del ojo.
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica

Legal Events

Date Code Title Description
FG Grant, registration